Regeneron, Sanofi announce EC approval for Dupixent
PremiumThe FlyRegeneron, Sanofi announce EC approval for Dupixent
11d ago
Sanofi says Beyfortus to be broadly available in more Canadian territories soon
Premium
The Fly
Sanofi says Beyfortus to be broadly available in more Canadian territories soon
19d ago
Judge blocks Tapestry-Capri deal, Centene reports Q3 beat: Morning Buzz
Premium
The Fly
Judge blocks Tapestry-Capri deal, Centene reports Q3 beat: Morning Buzz
23d ago
Sanofi announces presentation of Dupixent Phase 3 data in CSU
PremiumThe FlySanofi announces presentation of Dupixent Phase 3 data in CSU
24d ago
SNYNF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
SNYNF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
25d ago
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI, Reuters reports
Premium
The Fly
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI, Reuters reports
27d ago
Exscientia advances two additional discovery programs with Sanofi
PremiumThe FlyExscientia advances two additional discovery programs with Sanofi
1M ago
Election 2024: Where To Put Your Money Ahead of the Vote
Premium
The Fly
Election 2024: Where To Put Your Money Ahead of the Vote
1M ago
CD&R near EUR 15B deal for Sanofi consumer health unit, Bloomberg says
Premium
The Fly
CD&R near EUR 15B deal for Sanofi consumer health unit, Bloomberg says
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100